Your browser doesn't support javascript.
loading
Immunization with a self-assembling nanoparticle vaccine displaying EBV gH/gL protects humanized mice against lethal viral challenge.
Malhi, Harman; Homad, Leah J; Wan, Yu-Hsin; Poudel, Bibhav; Fiala, Brooke; Borst, Andrew J; Wang, Jing Yang; Walkey, Carl; Price, Jason; Wall, Abigail; Singh, Suruchi; Moodie, Zoe; Carter, Lauren; Handa, Simran; Correnti, Colin E; Stoddard, Barry L; Veesler, David; Pancera, Marie; Olson, James; King, Neil P; McGuire, Andrew T.
Afiliación
  • Malhi H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA 98109, USA.
  • Homad LJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA 98109, USA.
  • Wan YH; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA 98109, USA.
  • Poudel B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA 98109, USA.
  • Fiala B; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
  • Borst AJ; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
  • Wang JY; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
  • Walkey C; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
  • Price J; Clinical Research Division, Fred Hutchinson Cancer Research Center Seattle, WA 98109, USA.
  • Wall A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA 98109, USA.
  • Singh S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA 98109, USA.
  • Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA 98109, USA.
  • Carter L; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
  • Handa S; Clinical Research Division, Fred Hutchinson Cancer Research Center Seattle, WA 98109, USA.
  • Correnti CE; Clinical Research Division, Fred Hutchinson Cancer Research Center Seattle, WA 98109, USA.
  • Stoddard BL; Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Veesler D; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
  • Pancera M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA 98109, USA.
  • Olson J; Clinical Research Division, Fred Hutchinson Cancer Research Center Seattle, WA 98109, USA.
  • King NP; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
  • McGuire AT; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA 98109, USA; Department of Global Health, University of Washington, Seattle, WA 98195, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle WA 98115, USA. Electronic address:
Cell Rep Med ; 3(6): 100658, 2022 06 21.
Article en En | MEDLINE | ID: mdl-35705092
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas / Infecciones por Virus de Epstein-Barr / Nanopartículas Idioma: En Revista: Cell Rep Med Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas / Infecciones por Virus de Epstein-Barr / Nanopartículas Idioma: En Revista: Cell Rep Med Año: 2022 Tipo del documento: Article